NCT01023386View on ClinicalTrials.gov

A Clinical Pharmacological Study of YM155 After Intravenous Infusion in Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Cancer
Interventions
DRUG

YM155

I.V.

Trial Locations (1)

1122

Budapest

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01023386 - A Clinical Pharmacological Study of YM155 After Intravenous Infusion in Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter